Referência de medicamentos
Sparsentan
Sparsentan is a medicine in the class genitourinary. It is used for nephropathy.
- Classe do medicamento: Genitourinary
- Indicado para: nephropathy
Última atualização Fontes: US FDA label
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Pontos-chave
- Classe do medicamento
- Genitourinary
- Código ATC
- C09XX01
- Formas farmacêuticas comuns
- comprimido
- Interações conhecidas
- 139 (Contraindicada: 24 · Grave: 30 · Moderada: 68 · Leve: 17)
- Nomes comerciais
- 2
- Países e mercados
- 2
Para que é usado
Como funciona
Single molecule that antagonizes the endothelin type A receptor (ETAR) and the angiotensin II type 1 receptor (AT1R), both thought to be involved in the pathogenesis of IgAN and FSGS.
Dose habitual em adultos (resumo da bula)
IgAN (adults): start 200 mg orally once daily; after 14 days increase to 400 mg once daily, as tolerated
Gravidez e amamentação
- Gravidez
- Unsafe Contraindicated in pregnancy: in rats it caused craniofacial and skeletal malformations and fetal death at 10 times human exposure (endothelin and angiotensin blockade). Exclude pregnancy before and during treatment; use effective contraception until 1 month (EU) or 2 weeks (US) after stopping.
- Amamentação
- Unknown No human milk data. US label: do not breastfeed (possible infant low blood pressure); EU: should not be used while breastfeeding. LactMed has no data and repeats the maker's advice. Prefer not to breastfeed during treatment.
Efeitos adversos relatados
- Hyperkalemia
- Hypotension (including orthostatic hypotension)
- Peripheral edema
- Dizziness
- Anemia
- Acute kidney injury
Advertências de caixa preta
- Hepatotoxicity: available only through the restricted FILSPARI REMS. Aminotransferase elevations of at least 3-times ULN occurred in up to 3.5% of patients. Measure transaminases and bilirubin before treatment and every 3 months; interrupt and monitor if above 3-times ULN. Generally avoid in patients with baseline aminotransferases above 3-times ULN.
Contraindicações
- Pregnancy
- Concomitant use with ARBs, ERAs, or aliskiren
Quem deve ter cuidado
- Hepatotoxicity: monitor aminotransferases and bilirubin; stop and seek medical attention if symptoms of liver injury occur.
- Hypotension: consider adjusting other antihypertensives; consider dose reduction or interruption if it develops.
- Acute kidney injury: monitor kidney function periodically; patients with renal artery stenosis, CKD, severe heart failure or volume depletion are at particular risk.
Informe ao farmacêutico ou ao médico sobre gravidez ou amamentação, doença renal ou hepática, alergias e todos os outros medicamentos ou suplementos que você usa.
Principais interações (139)
- Aliskiren + Sparsentan Contraindicated
- Amlodipine-hydrochlorothiazide-valsartan + Sparsentan Contraindicated
- Amlodipine-olmesartan + Sparsentan Contraindicated
- Amlodipine-olmesartan-hydrochlorothiazide + Sparsentan Contraindicated
- Amlodipine-valsartan + Sparsentan Contraindicated
- Azilsartan + Sparsentan Contraindicated
- Azilsartan-chlorthalidone + Sparsentan Contraindicated
- Bosentan + Sparsentan Contraindicated
- Candesartan + Sparsentan Contraindicated
- Candesartan-hydrochlorothiazide + Sparsentan Contraindicated
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para abrir a monografia completa de Sparsentan: doses, gravidez e amamentação, efeitos adversos, advertências e todas as interações.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
- IV preparation and dilution
Experimente o Pro+ grátis por 14 dias na web. Sem cartão.
Perguntas frequentes
What is Sparsentan used for?
Sparsentan is a medicine in the class genitourinary. It is used for Nephropathy.
What side effects have been reported with Sparsentan?
Hyperkalemia, Hypotension (including orthostatic hypotension), Peripheral edema, Dizziness, Anemia, Acute kidney injury. Serious warning: Hepatotoxicity: available only through the restricted FILSPARI REMS.
Can Sparsentan be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. Contraindicated in pregnancy: in rats it caused craniofacial and skeletal malformations and fetal death at 10 times human exposure (endothelin and angiotensin blockade). Exclude pregnancy before and during treatment; use effective contraception until 1 month (EU) or 2 weeks (US) after stopping. Breastfeeding: Unknown. No human milk data. US label: do not breastfeed (possible infant low blood pressure); EU: should not be used while breastfeeding. LactMed has no data and repeats the maker's advice. Prefer not to breastfeed during treatment.
What does Sparsentan interact with?
MediHelp lists 139 known interactions for Sparsentan. Contraindicated: 24 · Major: 30 · Moderate: 68 · Minor: 17. The most serious include Aliskiren, Amlodipine-hydrochlorothiazide-valsartan, Amlodipine-olmesartan.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
